SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-023095
Filing Date
2024-02-29
Accepted
2024-02-29 16:15:41
Documents
107
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K adpt-20231231.htm   iXBRL 10-K 3065875
2 EX-23.1 adpt-ex23_1.htm EX-23.1 5912
3 EX-31.1 adpt-ex31_1.htm EX-31.1 16550
4 EX-31.2 adpt-ex31_2.htm EX-31.2 17892
5 EX-32.1 adpt-ex32_1.htm EX-32.1 10150
6 EX-32.2 adpt-ex32_2.htm EX-32.2 11326
7 EX-97.1 adpt-ex97_1.htm EX-97.1 50585
8 GRAPHIC img63237988_0.jpg GRAPHIC 426186
9 GRAPHIC img63237988_1.jpg GRAPHIC 631041
10 GRAPHIC img63237988_2.jpg GRAPHIC 22772
11 GRAPHIC img63237988_3.jpg GRAPHIC 1778
12 GRAPHIC img63237988_4.jpg GRAPHIC 438703
13 GRAPHIC img63237988_5.jpg GRAPHIC 504757
14 GRAPHIC img63237988_6.jpg GRAPHIC 151363
  Complete submission text file 0000950170-24-023095.txt   16269818

Data Files

Seq Description Document Type Size
15 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT adpt-20231231.xsd EX-101.SCH 1664911
108 EXTRACTED XBRL INSTANCE DOCUMENT adpt-20231231_htm.xml XML 2005287
Mailing Address 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address 1165 EASTLAKE AVE E SEATTLE WA 98109 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

IRS No.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38957 | Film No.: 24703854
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)